MYP_001109
Basic Information
HR2-9
Antimicrobial
Antiviral
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
37 amino acids
C176H302N50O60
Standard
Sequence
ISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGK
Physicochemical Analysis
4078.58 Da
4.66
-2.23
-2.44
-0.0603
-0.19
0.70
-0.01
39.41
134.32
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1837.00
-19.47
60.0
58.0
147.0
286.0
0.0
43.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0201661 VERIFIED: YES
Provenance & Taxonomy
Severe acute respiratory syndrome-related coronavirus [Virus]
Heptad repeat peptide
694009;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
SARS coronavirus (Virus entry); 293T
Luciferase assay
RECORD: Rec_0215283 VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Antimicrobial
RECORD: Rec_0233908 VERIFIED: YES
Provenance & Taxonomy
Severe acute respiratory syndrome-related coronavirus [Virus]
HR2-derived fusion inhibitor
694009
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Severe acute respiratory syndrome coronavirus
EC50